21-30 of 39 results

Spotlight: Cyber breach at Target
Insight 05 Sep 2017

There's a joke in the cyber security industry that there are two types of companies: those that know they have been hacked, and those that haven't yet found out. In November 2013, Target Corporatio ...

ACCC's Enforcement and Compliance priorities for 2017
Insight 27 Feb 2017

Criminal cartels, unfair contract terms, consumer guarantees and the health, construction and agriculture sectors are some of the ACCC's key enforcement and compliance priorities for 2017. ACCC ...

Assessment of biosimilars - Is Australia leading, following or going its own way?
Insight 26 Oct 2016

Special Counsel Special Counsel Ric Morgan Because biosimilars and their reference biologic medicine are not identical, whether compared to each other or even between biosimilars, it is important to know which product has been used. ...

Protecting investment in biologic medicines - biological medicines, biosimilars and the challenges they pose
Insight 15 Sep 2016

Special Counsel Special Counsel Ric Morgan This series of articles is directed towards the part of biotech that is 'pharmaceutical', rather than diagnostic or bioengineering technologies, and, in particular, towards biologic medicines. ...

What's in a (biosimilar) name?
Insight 08 Sep 2016

Special Counsel Special Counsel Ric Morgan Because biosimilars and their reference biologic medicine are not identical, whether compared to each other or even between biosimilars, it is important to know which product has been used. ...

Costs before Caution - Australia's unique approach to the interchangeability of biosimilars
Insight 17 Aug 2016

Special Counsel Special Counsel Ric Morgan Recent developments in Australia suggest that there has been a deliberate prioritisation of the cost benefits of facilitating biosimilar interchangeability over the safety and efficacy risks ...

Discussion Paper: Biologic medicines and biosimilars in the Australian landscape - The challenges and the opportunities
Insight 01 Aug 2016

Special Counsel Special Counsel Ric Morgan Allens is engaging with stakeholders on the challenges and opportunities presented by biosimilars. Ric Morgan Ric Ric Morgan Morgan As part of this engagement, we highlight a number of ...

Protecting innovation without patents - data exclusivity and market exclusivity
Insight 19 Jul 2016

Download a PDF copy of the paper: Protecting innovation without patents – data exclusivity and market exclusivity . Developments in patent law and the consequential limitations on patentability for ...

Predictive coding: the future of electronic document production?
Insight 25 Feb 2016

A recent decision of the English High Court may pave the way for the use of 'predictive coding' in large scale discovery and regulatory investigations in Australia. Partners Nick Rudge and Duncan ...

Refine

From
To